Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Vigil Neuroscience, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- +9 vs. Q4 2023
- Shares held
- 26.5M
- +1.75M (+7.1%) vs. Q4 2023
- Total value
- $90.5M
- +$6.83M (+8.2%) vs. Q4 2023
- New holders
- 12
- 10 more added
- Sold out
- 3
- 15 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 1 | $0 | 0.00% | +1 | New |
| Capital Advisors, Ltd. LLC | 4 | $0 | 0.00% | +4 | New |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 2 | $6 | 0.00% | +2 | New |
| Royal Bank of Canada | 367 | $1.00K | 0.00% | −3,920−91.4% | Reduced |
| Federated Hermes, Inc. | 317 | $1.08K | 0.00% | +317 | New |
| Amalgamated Bank | 542 | $2.00K | 0.00% | −860−61.3% | Reduced |
| Ameritas Investment Partners, Inc. | 1,327 | $4.53K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,554 | $5.27K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,650 | $5.63K | 0.00% | −139,184−98.8% | Reduced |
| Wells Fargo & Company | 5,655 | $19.3K | 0.00% | +729+14.8% | Added |
| Tower Research Capital LLC (TRC) | 5,789 | $19.7K | 0.00% | +2,906+100.8% | Added |
| JPMorgan Chase & Co | 7,116 | $24.3K | 0.00% | −3,299−31.7% | Reduced |
| STRS Ohio | 7,700 | $26.0K | 0.00% | −500−6.1% | Reduced |
| American International Group, Inc. | 7,919 | $27.0K | 0.00% | −68−0.9% | Reduced |
| New York State Common Retirement Fund | 10,140 | $34.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 16,151 | $55.1K | 0.00% | +16,151 | New |
| Rhumbline Advisers | 17,953 | $61.2K | 0.00% | +684+4.0% | Added |
| Goldman Sachs Group Inc | 18,239 | $62.2K | 0.00% | −66,861−78.6% | Reduced |
| Bank of America Corp | 18,939 | $64.6K | 0.00% | −10,095−34.8% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 19,178 | $65.4K | 0.00% | +19,178 | New |
| Prelude Capital Management, LLC | 20,377 | $69.5K | 0.00% | +20,377 | New |
| Morgan Stanley | 23,362 | $79.7K | 0.00% | −31,552−57.5% | Reduced |
| Two Sigma Advisers, LP | 24,100 | $82.2K | 0.00% | +24,100 | New |
| Nuveen Asset Management, LLC | 26,840 | $91.5K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 33,129 | $113.0K | 0.00% | +33,129 | New |
| PEAK6 Investments LLC | 41,486 | $141.5K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 41,968 | $143.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 44,998 | $153.4K | 0.00% | +29,270+186.1% | Added |
| Bank of New York Mellon Corp | 45,750 | $156.0K | 0.00% | −2,738−5.6% | Reduced |
| Bridgeway Capital Management, LLC | 57,964 | $197.7K | 0.00% | −75,000−56.4% | Reduced |
| Renaissance Technologies LLC | 59,964 | $204.0K | 0.00% | +59,964 | New |
| Citigroup Inc | 67,310 | $229.5K | 0.00% | +658+1.0% | Added |
| Bank of Montreal | 33,368 | $234.9K | 0.00% | +33,368 | New |
| DAFNA Capital Management LLC | 71,815 | $244.9K | 0.06% | 00.0% | Unchanged |
| Barclays PLC | 113,036 | $385.5K | 0.00% | −10,759−8.7% | Reduced |
| Northern Trust Corp | 138,720 | $473.0K | 0.00% | −2,681−1.9% | Reduced |
| Ensign Peak Advisors, Inc | 228,674 | $779.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 286,063 | $975.5K | 0.00% | +2,772+1.0% | Added |
| ArrowMark Colorado Holdings LLC | 289,460 | $987.1K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 334,242 | $1.14M | 0.00% | +18,704+5.9% | Added |
| OrbiMed Advisors LLC | 448,891 | $1.53M | 0.03% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $1.61M | 0.04% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $1.91M | 1.23% | 00.0% | Unchanged |
| BlackRock Inc. | 877,032 | $2.99M | 0.00% | −42,100−4.6% | Reduced |
| Vanguard Group Inc | 894,473 | $3.05M | 0.00% | +95,276+11.9% | Added |
| Deerfield Management Company, L.P. (Series C) | 980,311 | $3.34M | 0.06% | −193,212−16.5% | Reduced |
| 683 Capital Management, LLC | 994,900 | $3.39M | 0.35% | +994,900 | New |
| Deep Track Capital, LP | 1,594,931 | $5.44M | 0.16% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,730,414 | $5.90M | 0.96% | +1,195,294+223.4% | Added |
| Artal Group S.A. | 1,811,191 | $6.18M | 0.16% | 00.0% | Unchanged |
| BVF Inc | 1,813,633 | $6.18M | 0.17% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,165,811 | $7.39M | 0.01% | +3,909+0.2% | Added |
| Northpond Ventures, LLC | 4,214,498 | $14.4M | 14.00% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $19.9M | 1.84% | 00.0% | Unchanged |
| Anson Funds Management LP | 0 | $0 | 0.00% | −207,016−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,178−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −2,645−100.0% | Sold out |
| Trustees of Columbia University in the City of New York | – | – | – | – | Not filed |